These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 8921963

  • 1. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S.
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [Abstract] [Full Text] [Related]

  • 2. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
    DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET.
    Cell Immunol; 1995 Oct 01; 165(1):33-43. PubMed ID: 7671323
    [Abstract] [Full Text] [Related]

  • 3. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 4. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR, Renauld JC, Houssiau FA.
    Cytokine; 1999 Nov 15; 11(11):822-30. PubMed ID: 10547269
    [Abstract] [Full Text] [Related]

  • 5. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA.
    J Immunol; 1999 Apr 15; 162(8):4511-20. PubMed ID: 10201989
    [Abstract] [Full Text] [Related]

  • 6. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A, Visonneau S, Clark SC, Santoli D.
    J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216
    [Abstract] [Full Text] [Related]

  • 7. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 8. Acidic pH inhibits non-MHC-restricted killer cell functions.
    Fischer B, Müller B, Fischer KG, Baur N, Kreutz W.
    Clin Immunol; 2000 Sep 15; 96(3):252-63. PubMed ID: 10964544
    [Abstract] [Full Text] [Related]

  • 9. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.
    Clement MV, Haddad P, Soulie A, Guillet J, Sasportes M.
    Nouv Rev Fr Hematol (1978); 1990 Sep 15; 32(5):349-52. PubMed ID: 2099410
    [Abstract] [Full Text] [Related]

  • 10. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors.
    Robinet E, Kamoun M, Farace F, Chouaib S.
    Eur J Immunol; 1992 Nov 15; 22(11):2861-5. PubMed ID: 1358624
    [Abstract] [Full Text] [Related]

  • 12. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB, Gutterman JU, Grimm EA.
    Cancer Res; 1988 Feb 15; 48(4):788-92. PubMed ID: 3257408
    [Abstract] [Full Text] [Related]

  • 13. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1988 Feb 15; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 14. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL, Weaver AM, Brinckerhoff LH, Deacon DH, Gonias SL, Slingluff CL.
    J Immunother; 1998 Mar 15; 21(2):85-94. PubMed ID: 9551359
    [Abstract] [Full Text] [Related]

  • 15. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr 15; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 16. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M, Meadows SK, Wira CR, Sentman CL.
    J Leukoc Biol; 2004 Sep 15; 76(3):667-75. PubMed ID: 15178706
    [Abstract] [Full Text] [Related]

  • 17. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R, Li AL, Wei HM, Tian ZG.
    Cell Res; 2004 Feb 15; 14(1):67-73. PubMed ID: 15040892
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B, Gately M, Espevik T.
    J Immunol; 1992 Apr 15; 148(8):2429-36. PubMed ID: 1373169
    [Abstract] [Full Text] [Related]

  • 19. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 20. Regulation of NK cell functions by TGF-beta 1.
    Bellone G, Aste-Amezaga M, Trinchieri G, Rodeck U.
    J Immunol; 1995 Aug 01; 155(3):1066-73. PubMed ID: 7636180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.